About this trial
The general objective of the proposed project is to characterise phenotypically and functionally ADAMTS13-specific memory B lymphocytes and autoreactive T lymphocytes, in particular follicular helper T lymphocytes, in the acute phase of the disease, but also during its progression after treatment. The aim is to highlight their contribution to the initial pathogenic process, their evolution under treatment, and also their involvement in patients who are refractory to immunosuppressive therapies and during relapses. The aim of this project is to identify early phenotypic or functional parameters that are predictive of relapse and that can be used for personalised optimisation of treatment to maintain remission.
Eligibility criteria
Qualifiers
age over 18
patients with TTP at any stage of diagnosis (acute phase, lasting remission or not, relapse)
patients undergoing internal medicine at Rouen University Hospital
people who have read and understood the information letter
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed